Expecting mothers strive to take care of themselves and their unborn child by eating a balanced diet and taking the proper vitamins, but many wonder if these same precautions should be taken when considering taking medication while pregnant. Vyvanse is a prescription medication used for the treatment of attention-deficit/hyperactivity disorder (ADHD) and binge eating disorder. The drug has become increasingly popular in recent years due to its efficacy, however, there is still a lot of uncertainty surrounding its safety for expectant mothers. This blog post will explore the question “Can I Take Vyvanse While Pregnant?” by discussing the risks and benefits of taking the medication while pregnant and providing mothers-to-be with the necessary information to make an informed decision.
These are typical queries pregnant women may have: is it safe to take Vyvanse while pregnant and, if not, how should ADHD be treated at this time? Lisdexamfetamine is the generic name for the active ingredient found in the stimulant drug Vyvanse. Vyvanse is a once-daily medication that can be prescribed for adults, adolescents, and children ages 6 to 12. Because Vyvanse is a controlled substance, there is a chance that it will be abused and that it will lead to addiction. In addition to being used to treat binge eating disorder, lisdexamfetamine also stimulates the central nervous system. Lisdexamfetamine is paired with the amino acid L-lysine and shares a chemical structure with dextroamphetamine. Serious or deadly side effects can rarely occur with Vyvanse. Cardiac issues are one of these effects, especially for those with a history of heart issues. An elevated blood pressure and an abrupt stroke are additional possibilities. People with a history of heart issues, certain mental health issues, or circulation issues shouldn’t take Vyvanse. It shouldn’t be combined with MAOIs either. Vyvanse can cause anxiety, decreased appetite, dizziness, diarrhea, dry mouth, and irritability as more frequent and milder side effects.
The Recovery Village provides factual information about behavioral health conditions, available treatments, and the results of those treatments in order to enhance the quality of life for people who are battling substance abuse or mental illness. We only release content that has been examined, edited, and reviewed by qualified medical professionals. The information we offer is not meant to replace expert medical guidance, diagnosis, or treatment. It should not be used as a substitute for advice from your doctor or other skilled healthcare professionals.
The first step is to speak with your healthcare provider if you already take Vyvanse and intend to get pregnant or are already pregnant. Your hormones and emotions frequently fluctuate during pregnancy, which can make ADHD symptoms more noticeable and challenging to manage. However, if the risks of the medication outweigh any potential advantages, your doctor may advise you to stop taking Vyvanse and other ADHD medications. In order to manage symptoms while you are pregnant, your doctor may suggest that you change some aspects of your lifestyle or engage in a treatment option like talk therapy. Do not abruptly stop taking Vyvanse without first consulting a healthcare professional.
You might want to discuss the potential risks of taking Vyvanse while pregnant with your doctor. For instance, Vyvanse might make you less hungry, which might result in inadequate nutrition. This can be risky for you and your unborn baby. Drugs like Vyvanse and stimulants can also increase blood pressure and heart rate, which can increase the risk of specific pregnancy complications. There is some evidence that high doses of amphetamine can cause birth defects in animal studies. Prenatal exposure to amphetamine in animals resulted in long-term learning and memory issues as well as changes to overall neural function. However, there are no well-controlled studies examining the effects on human pregnancy. Use of stimulants like Vyvanse during pregnancy increases the risk of preterm birth and low birth weight in the unborn child. Additionally, it’s conceivable that stimulants like Vyvanse could reduce a fetus’s blood flow.
The exposure to neonatal stimulants carries the additional risk of withdrawal symptoms developing. Agitation and sleep disturbances are two signs of Vyvanse withdrawal in newborns. Stimulants like Vyvanse aren’t considered safe while breastfeeding, either. The medication can cause symptoms in a newborn and pass through breast milk. These signs may include anorexia, agitation, and sleep disorders like insomnia. Also possible is a failure to thrive.
Between 1998 and 2014, 29,540 women were interviewed; 87 of them disclosed having taken an ADHD medication. Despite the fact that there was no medication for ADHD used at all generally, 3%, there was a marked increase in the prevalence of use over the period of the study, from 0 2% for women with LMP dates in 1997–98 to 1. 3% for women with LMP dates in 2013 (2-sided Cochran-Armitage test for trend: p 0001), ). We looked at the prevalence of use for LMP year 2012 depending on whether the interviews were conducted before or after the change because the mid-2013 addition of a specific ADHD indication prompt affected women with LMP dates in 2012. Prior to the new prompt’s introduction, 902 subjects with LMPs were interviewed in 2012; use at that time was 0. 9%; among the 1,352 interviewed with the new prompt, the prevalence was 1 0%. We therefore combined the pre- and post-modification data.
We looked at trends for each center (Boston, 9,476; Philadelphia, 7,970; Toronto, 3,323; San Diego, 4,969; New York, 3,531; Tennessee, 271) separately for cases (19,811) and controls (9,729). Both factors failed to account for the secular trends, which were most pronounced in the centers with the largest sample sizes.
Drs. Lilly, the company that makes Strattera, paid Louik and Mitchell’s salaries in order to help them create a protocol for a study on the safety of duloxetine during pregnancy. The company was not involved with or even aware of the analysis that was submitted.
From 1998 to 2013, we noticed a noticeably rising trend in the use of ADHD medications during pregnancy. This is not surprising given other reports showing that use of these drugs is rising among adults2, 8 Only one other study, carried out in Denmark, that we are aware of, looked at trends in the use of ADHD medications specifically among pregnant women9. Because pregnant women are a special population for whom exposure carries a potential risk for both the woman herself and the fetus she is carrying, our observation, along with similar findings from Denmark through 2010, raises particular concern. Methylphenidate has not been found to be teratogenic in studies on mice or rats; only doses that were about 40 times the highest dose advised for humans increased the risk of spina bifida in rabbits10 Amphetamines given orally in doses approximately 1. In pregnant mice and rabbits, doses of 5 and 8 times the average human dose had no apparent effects on fetal development, though parenteral doses of about 6 times the average human dose caused fetal malformations in mice. 11 It’s important to remember, though, that studies conducted on animals do not always predict how something will affect people.12 Teratogenicity in animals does not always translate into teratogenicity in people, and vice versa.13
Amphetamine mixed salts (Adderall®/Adderall XR® and generics), which accounted for 57 reports, were the most frequently used ADHD medication. 5% of total exposures. For the LMP years 1997–1998 there were no reports of this product’s use, but for the LMP year 2013 there was one report. 0% (2-sided Cochran-Armitage test for trend: p<. 0001,); this rise fully explains the rise in prescriptions for ADHD medications. Other medications included atomoxetine HCl (Strattera®), lisdexamfetamine dimesylate (Vyvanse®), and methylphenidate (Ritalin®, Concerta®, and generics), accounting for 29. 9. 5. 7, and 3. 4% of total exposures, respectively.
Is Vyvanse safe to take while breastfeeding?
“It does cross over through breast milk,” says Danielle Plummer, Pharm.D., founder of HG Pharmacist. “The baby is then potentially going to go through withdrawal when you wean them from nursing.” Caregivers should carefully watch babies born to or breastfed by mothers taking Vyvanse for withdrawal symptoms like trouble feeding, irritability, distress, and extreme drowsiness. Some experts recommend that women avoid breastfeeding while using this medication.
When should I stop taking Vyvanse during pregnancy?
Can you be on stimulants while pregnant?
Among women taking prescription stimulant medications, there was a small increased risk of preeclampsia and preterm birth. Among women who filled at least two prescriptions for stimulants between 8 and 18 weeks, the risk of placental abruption increased.
Does ADHD medication affect pregnancy?
What helps with ADHD during pregnancy?